about
Review of pharmacological treatment in mood disorders and future directions for drug development.Behavioural traits propagate across generations via segregated iterative-somatic and gametic epigenetic mechanisms.50 years of hurdles and hope in anxiolytic drug discoveryInfluence of early stress on social abilities and serotonergic functions across generations in miceThe relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practiceIncreased anxiety in corticotropin-releasing factor type 2 receptor-null mice requires recent acute stress exposure and is associated with dysregulated serotonergic activity in limbic brain areas.Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI ExposureDevelopmental effects of serotonin 1A autoreceptors on anxiety and social behavior.Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists.Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5-HT1A receptor expressionEffects of early-life stress on serotonin(1A) receptors in juvenile Rhesus monkeys measured by positron emission tomographyOptogenetic insights on the relationship between anxiety-related behaviors and social deficits.Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy.Conceptualizing the role of estrogens and serotonin in the development and maintenance of bulimia nervosa.Effective microPET imaging of brain 5-HT(1A) receptors in rats with [(18) F]MeFWAY by suppression of radioligand defluorination.Evaluation of serotonin 5-HT(1A) receptors in rodent models using [¹⁸F]mefway PET.Optimization of the radiosynthesis of [(18) F]MEFWAY for imaging brain serotonin 1A receptors by using the GE TracerLab FXFN-Pro module.Translational possibility of [(18) F]Mefway to image serotonin 1A receptors in humans: Comparison with [(18) F]FCWAY in rodents.Activity-dependent serotonergic excitation of callosal projection neurons in the mouse prefrontal cortex.Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.5-HT radioligands for human brain imaging with PET and SPECTAutoradiographic evaluation of [3H]CUMI-101, a novel, selective 5-HT1AR ligand in human and baboon brain.Biodistribution, toxicology, and radiation dosimetry of 5-HT1A-receptor agonist positron emission tomography ligand [11C]CUMI-101.In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat.Distinctive in vitro signal transduction profile of NLX-112, a potent and efficacious serotonin 5-HT1A receptor agonist.Iloperidone, asenapine and lurasidone: a primer on their current status.An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial.Comparison of psychological symptoms and serum levels of neurotransmitters in Shanghai adolescents with and without internet addiction disorder: a case-control studyThe functional -1019C/G HTR1A polymorphism and mechanisms of fear.Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxietyTranscriptional dysregulation of 5-HT1A autoreceptors in mental illness.Modulation of anxiety by cortical serotonin 1A receptorsEffects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging.Brain serotonergic circuitries18F-Mefway PET imaging of serotonin 1A receptors in humans: a comparison with 18F-FCWAYDivergent effects of the 'biased' 5-HT1 A receptor agonists F15599 and F13714 in a novel object pattern separation task.A role for 5-HT1A receptors in the basolateral amygdala in the development of conditioned defeat in Syrian hamsters.Environmental Enrichment Reduces Anxiety by Differentially Activating Serotonergic and Neuropeptide Y (NPY)-Ergic System in Indian Field Mouse (Mus booduga): An Animal Model of Post-Traumatic Stress Disorder.Therapeutic potential of metabotropic glutamate receptor modulators.Denial of reward in the neonate shapes sociability and serotonergic activity in the adult rat
P2860
Q26853509-5C7CFD30-4DD7-4A18-858D-9B9CCAE904ACQ27317789-807E7B6F-C591-4AEF-A7D4-90FEA1DE27C8Q28297569-6A2807D7-5CBE-49F0-B2F1-5E94181D54E5Q28742204-0700791D-AF70-4A19-A343-9BD205AF4F28Q30251737-8FCFA8E0-6B9E-467D-91A1-3AE7B8E83A93Q30438084-A691DB70-66CE-4EC0-B640-DC36C9AE6607Q30469931-F1D41A17-3ED9-41AC-911E-CCD53030D871Q30560441-E25E4ED3-0D68-40A0-8401-D23D794435B8Q33687521-D3FE25E6-EFBA-4FA0-B199-F2429B801860Q33719414-03A733C9-AB2D-46F5-87CB-7AE94802A1C3Q33900907-9764AFF3-74C8-4036-990B-7DE35894B14EQ33906973-1EDC95C6-786A-4583-BC37-599224A51AAEQ34008064-C99D43A2-5897-4595-985E-3615B3272C42Q34020568-05386355-7C78-4C5A-AFF8-8E36D4796030Q34033357-71ED01EF-F099-4518-A744-57683AF88746Q34036060-C48DEFDF-2220-426B-A50A-C3DC6BB809CEQ34039144-EA43BCEF-2A2D-4354-B66D-F7D3044D9C78Q34041532-13F77E8B-5C3C-48B7-AB3F-81FD048E08BDQ34087741-1C79E980-C4EB-4AE1-9462-A0DED6FE8786Q34169978-6DA76846-5790-47B1-86AB-AA7BF7648557Q34192729-E2C9377C-85C5-4BDB-9B72-1F58FAF7B669Q34214169-A5CE6839-B82D-4FA8-A7B2-F8868A016899Q34214178-1ECFA190-DE0E-4CE4-9069-6C5865FD6C52Q34238841-AAC7E229-6542-459B-A6CD-5F64E7A3799AQ34557860-8024729D-FA3B-4FD4-B0E0-AD0AC4883015Q34641024-B05D4C39-271D-4ECD-A87A-DCD3F170AC0DQ34668638-FA520CDC-AA61-4501-8A97-0D99021C961BQ34712943-B2959858-98D8-4E79-9C65-8CB5BF307525Q34731221-DD536D56-D8B1-4B31-ADA5-8F9E101101E3Q35008700-9F42EB0C-FAB8-44D1-B41D-22DFBB8D53B6Q35089158-0E767A47-5562-46DB-8BA2-B788D5DF1E2CQ35115387-66DAAAFC-8BA1-4C2A-97BB-0C132E374C77Q35178976-94AF0177-3DE7-4C13-BFA5-B8E500ED8DF1Q35237299-63BA7CEF-8BF2-406B-ACD3-F7E11578A2CFQ35241015-46053828-9024-4D4D-9F33-6A2E65677E0DQ35538516-32986324-52BA-4954-B1D2-FE5B25E7697BQ35623946-3EB3B5D4-571F-47E9-9922-224EFB83A845Q35656433-BD0C1FA2-6228-4F5E-B651-7EC0E3E4AFE4Q35778704-CBF7D6A0-F61D-40FB-9477-5EC7758DDB74Q35856639-507B60CB-0CD8-41FF-984C-03571FB7662C
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The serotonin-1A receptor in anxiety disorders.
@ast
The serotonin-1A receptor in anxiety disorders.
@en
The serotonin-1A receptor in anxiety disorders.
@nl
type
label
The serotonin-1A receptor in anxiety disorders.
@ast
The serotonin-1A receptor in anxiety disorders.
@en
The serotonin-1A receptor in anxiety disorders.
@nl
prefLabel
The serotonin-1A receptor in anxiety disorders.
@ast
The serotonin-1A receptor in anxiety disorders.
@en
The serotonin-1A receptor in anxiety disorders.
@nl
P1476
The serotonin-1A receptor in anxiety disorders.
@en
P2093
Elena Akimova
P304
P356
10.1016/J.BIOPSYCH.2009.03.012
P407
P577
2009-05-07T00:00:00Z